All Episodes
Keeping Current — 630 episodes · page 1 of 7
Frontiers in Modern Oncology: Molecular-Guided Strategies for HR-Positive/HER2-Negative Metastatic Breast Cancer
Navigating IgA Nephropathy Management in an Evolving Treatment Landscape: Key Considerations for Treatment Selection
Antibody-Drug Conjugate Therapy for Early Breast Cancer: Innovations That Shape the Future of Care
Solving the Alzheimer's Disease Biomarker Puzzle: Live, European Peer Workshop
Advancing Uveitic Macular Edema Management: What's New?
Patient Journeys With IgA Nephropathy: Optimizing Outcomes in Patient Care
Refining Adjuvant Therapy in HR-Positive/HER2-Negative Early Breast Cancer: Personalizing Care in the CDK4/6 Inhibitor Era
The Patient Journey With Severe Refractory Autoimmune Rheumatic Diseases: Exploring the Potential for CAR T-Cell Therapies
Translating Molecular Insights Into Practice for HR-Positive/HER2-Negative Metastatic Breast Cancer
Targeting the Metabolic Driver: A Forward-Looking Approach to Obesity and Liver Health
The Whole Patient: Integrating the Lived Experience of Myasthenia Gravis
Epilepsy in General Neurology Practice: Optimizing a Therapeutic Approach From the Start
Myasthenia Gravis Guidelines: A Global View for Local Practice
From Mechanism to Management: Applying Evidence for Hemophilia A in the Clinic
Updating Our Checklist for Transthyretin Amyloid Cardiomyopathy Monitoring
Mild Cognitive Impairment and Mild Dementia: Can We Act Before It's Too Late?
Why Target APRIL in IgA Nephropathy Management? Get Up to Speed With the Mechanisms of Action and Key Data
Beyond Intervals: The Next Era of Continuous Delivery in Retinal Medicine
When and How Should I Optimize Heart Failure Treatments for My Patients?
The Evolving Diagnostic and Management Landscape for Progressive Familial Intrahepatic Cholestasis
Pharmacological and Combination Interventions for Nicotine Cessation
Is Normalizing Hemostasis an Achievable Goal in Hemophilia A?
The Top 5 Errors in Transthyretin Amyloid Cardiomyopathy Management
Better Drying? Longer Lasting? Second-Generation Anti-VEGF Therapies in Clinical Practice
Shaping the Future of Precision Oncology: Biomarker-Driven Care for Tumor-Agnostic Therapies
Navigating the Management of Alagille Syndrome Using Ileal Bile Acid Transporter (IBAT) Inhibitors
Chronic Inflammatory Demyelinating Polyradiculoneuropathy Care Partnerships: Aligning Goals for Better Outcomes
The Molecular Nuances of Hemostasis: Differentiating FVIII and Non-Factor Replacement
Depression and Neurological Diseases: What's the Link?
What Lies Beneath Generalized Myasthenia Gravis: Exploring Novel Mechanisms of Action of Emerging Therapies
Charting New Frontiers in Advanced Breast Cancer: Milestones, Missions, and Mastery
Beyond SGLT2: The Emerging Role of Dual SGLT1/2 Inhibition in Heart Failure
Addressing Unmet Needs in the Management of Sjögren's Disease: A Spotlight on Emerging Biologic Therapies
Challenges and Opportunities in the Diagnostic Pathway for Biliary Atresia
Diabetic Macular Edema: Express Q&A on What's New
The Science of SGLT1 and SGLT2: Unpacking Dual Inhibition for Heart Failure
Liver Fibrosis in Type 2 Diabetes and Obesity: A Case-Based Approach
Clinical Perspectives on the Use of PI3K/AKT Pathway Inhibitors in the Management of HR+/HER2− Metastatic Breast Cancer
New Horizons in Uveitic Macular Edema
Metabolic Crossroads: Navigating the Obesity–Liver Disease Axis
Beyond the Update in Advanced/Recurrent Endometrial Cancer: How Evidence Is Shaping New Guidelines
Beyond PSMA: Preparing Your Practice for the Next Wave of Prostate Cancer Biomarkers
Avoiding Common Mistakes in Managing Focal Epilepsy
From Prescription to Practice in Respiratory Diseases: Overcoming Barriers to Inhaler Adherence and Compliance
The CLL Consultation: Partnering With Patients for Person-Centred Care
Immunotherapy for Non-Muscle-Invasive Bladder Cancer: Expert Takeaways From the Latest Updates
Navigating the HER2 Spectrum in Breast Cancer: Evolving Diagnostic Paradigms for Clinical Excellence
2025 Winter Conference Update: Novel and Emerging Treatment Strategies for Breast Cancer
A Case-Based Journey From Risk to Results
HER2-Positive Early Breast Cancer: What the Latest Data Mean for Your Practice
Balancing ART and Comorbidities in Aging People Living With HIV
The Alarming Carbon Footprint of Respiratory Disease: The Future of Sustainable Inhaler Technology
Achieving Brain Health in Epilepsy: What Can Clinicians Do?
Patient Case Challenge: How Would You Manage This Patient With MASH?
Navigating the Challenges of IgAN Management: Clinical Implications of Emerging B-Cell Therapies
Person-Centered Care in EGFR-Mutated Advanced NSCLC: Optimizing Outcomes and Experiences
Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy
How Are ADCs Shaping the Future of Early Breast Cancer Care? Latest Insights and Emerging Strategies
Pediatric Low-Grade Glioma With BRAF Alterations: Stories, Science, and Strategies
Hot Topics from Berlin 2025: What Experts Say About the Future of Metastatic Breast Cancer Care
How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer?
Staying Ahead of the First Event: Evaluating the Evidence for Early LDL-C Lowering
Optimizing Outcomes for Patients With IgAN: Novel B-Cell Targeted Therapies and the Changing Treatment Paradigm
Advances in the Pharmacologic Management of Obesity: An Expert Digest of the Latest Data
Breaking the Silence: Tackling Liver Fibrosis in MASH: Who to Treat With Novel Therapies
Coexisting Comorbidities: Advancing Holistic Care in COPD
Novel Biological Approaches for Enhanced Obesity and Diabetes Management – What's Next?
Latest Advances in mHSPC: An Update From Berlin 2025
Conference Insights: Breaking Developments in ALK-Positive NSCLC and ES-SCLC
Charting the Course for Metastatic Breast Cancer Care: Optimizing First-Line Treatment and Beyond
Paving the Way for Success in Integrating Biosimilars Into Multiple Sclerosis Care: Optimizing Communication
Advancing Personalized Care for Prostate Cancer: Patient-Centered Solutions for mHSPC and nmCRPC
Reshaping Obesity and Diabetes Care With Innovative Multiagonism Concepts
The Hidden Battle: Understanding Chronic Inflammation in Aging People Living With HIV and Comorbidities
Emerging Therapies for MASH: From Theory to Clinical Practice
Interpreting JC Virus Test Results in Multiple Sclerosis Management: Are You Up to Speed?
Targeting Diabesity From Multiple Angles: Future Prospects and Imminent Realities
Neovascular AMD: Optimizing Disease Control for Your Patients
The Hidden Hurdle: Practical Insights on Drug-Drug Interactions in Prostate Cancer Management
Managing Diabetic Macular Edema in Clinical Practice
Shaping the Future: Expert Insights on Perioperative Immunotherapy for Gastric/GEJ Cancers
Thyroid Eye Disease: How to Use Targeted Immunotherapy in Clinical Practice
Thyroid Eye Disease: How to Use Targeted Immunotherapy in Clinical Practice
Immunopathogenesis of IgAN and the Evolving Treatment Landscape: A Focus on the B-Cell Pathway
Targeted Therapies for NSCLC: Where Are We Today?
Advances in the Pharmacologic Management of Obesity: Looking Ahead to EASD 2025
Squamous Cell Anal Carcinoma: Bridging Current Practice and Future Horizons With Immunotherapy
Epilepsy Undertreatment and Overtreatment: How Can We Strike a Balance?
Illuminating the Path: New Insights in EGFR-Mutated Advanced NSCLC
Antibody-Drug Conjugates in Practice: Contemporary Questions for the Treatment of Metastatic Breast Cancer
JC Virus Testing 101: What You Need to Know About JC Virus Testing in Multiple Sclerosis Care
The Basis of Success: Recognizing IgAN and Promoting Earlier Diagnosis to Facilitate Treatment Initiation
Hormone Receptor-Positive Metastatic Breast Cancer: Novel Endocrine-Based Strategies and Options After Progression
Navigating Biomarker Conversations: Empowering Patient Understanding in Gastroesophageal Cancer
Long COVID in Context: A Closer Look at Post-Viral Syndrome and Management Approaches
Tumor-Like Masses, Abdominal Swelling, Pancreatic Involvement: Making Sense of IgG4-Related Disease, a Multiorgan Fibroinflammatory Condition
Monitoring ESR1 ctDNA During First-Line Care of HR-Positive Advanced Breast Cancer: A New Approach
ADA 2025 Highlights: The Weight of Evidence for Emerging Combination Therapies in Obesity and Diabetes Care
Advancing Treatment for HER2-Positive Advanced Breast Cancer: Expert Analysis of the Latest Developments
Personalized Pathways: Tailoring Care for Patients With Newly Diagnosed Multiple Myeloma